Loading
Main Content
Thursday November 12, 2020
12:30pm - 2pm Pharmaceutical and biotechnology companies are increasingly using digital tools and approaches to recruit patients for clinical trials and data, to assess and monitor patients’ health status and to communicate product information to patients and healthcare professionals.
Meredith Smith, PhD, MPA is Risk Management Director at Alexion Pharmaceuticals, Inc.
(HSI) Health Systems Initiative Seminar: Business Challenge: Uptake of digital risk minimization tools by healthcare professionals and patients with Meredith Smith, PhD, MPA
Registration
Registration is now closed (this event already took place).
Details
12:30pm - 2pm Pharmaceutical and biotechnology companies are increasingly using digital tools and approaches to recruit patients for clinical trials and data, to assess and monitor patients’ health status and to communicate product information to patients and healthcare professionals.
Meredith Smith, PhD, MPA is Risk Management Director at Alexion Pharmaceuticals, Inc.
Speakers
Meredith Smith, PhD, MPA
Risk Management Director
Alexion Pharmaceuticals, Inc.
Meredith Smith is Risk Management Director at Alexion Pharmaceuticals, Inc. She is a behavioral scientist and health services researcher. Meredith is on the board of the Rutgers University BioPharma Educational Initiative in the School of Health Professions and is an adjunct professor at the University of Southern California’s School of Pharmacy.